0001209191-15-084207.txt : 20151209 0001209191-15-084207.hdr.sgml : 20151209 20151209150240 ACCESSION NUMBER: 0001209191-15-084207 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151207 FILED AS OF DATE: 20151209 DATE AS OF CHANGE: 20151209 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENOMIC HEALTH INC CENTRAL INDEX KEY: 0001131324 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 770552594 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-556-9300 MAIL ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vaughn James J CENTRAL INDEX KEY: 0001649689 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51541 FILM NUMBER: 151278231 MAIL ADDRESS: STREET 1: C/O GENOMIC HEALTH, INC. STREET 2: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-12-07 0 0001131324 GENOMIC HEALTH INC GHDX 0001649689 Vaughn James J 301 PENOBSCOT DRIVE REDWOOD CITY CA 94063 0 1 0 0 Chief Commercial Officer Common Stock 2015-12-07 4 M 0 2000 18.89 A 26076 D Common Stock 2015-12-07 4 S 0 2000 29.334 D 24076 D Employee Stock Option (right to buy) 18.89 2015-12-07 4 M 0 2000 0.00 D 2016-11-30 Common Stock 2000 6000 D These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on September 9, 2015. Represents weighted average sale price. Actual sale prices ranged from $28.96 to $29.70. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated. Includes an aggregate of 16,327 shares of common stock issuable pursuant to previously reported restricted stock units and performance-based vesting restricted stock units awards that have not vested. The option became exercisable as to 25% of the shares on November 30, 2007, and became exercisable as to 1/48th of the shares each full month thereafter. /s/ G. Bradley Cole, Attorney-in-fact 2015-12-09